Literature DB >> 16835508

Incidence rates of acute promyelocytic leukemia among Hispanics, blacks, Asians, and non-Hispanic whites in the United States.

Matthew J Matasar1, Ellen K Ritchie, Nathan Consedine, Carol Magai, Alfred I Neugut.   

Abstract

Despite significant improvements in the prognosis of acute promyelocytic leukemia brought about by therapeutic advances, understanding of the epidemiology of acute promyelocytic leukemia remains limited. Earlier reports have suggested that Hispanics may have an increased incidence of acute promyelocytic leukemia, but no systematic analysis of national data has yet been reported. We performed a retrospective cohort study, using data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute from 1992-2001 in order to compare leukemia incidence rates as a function of race and ethnicity. We identified 709 cases of acute promyelocytic leukemia and analyzed incidence rates by race and sex. Hispanics were not found to have greater lifetime incidence rates than whites, with an incidence relative rate (IRR) of 0.86 that of whites (P=0.17). The age distribution among Hispanics was significantly different from non-Hispanic whites, with greater incidence rates for children ages 1-19 years (IRR=1.9, P=0.02) and adult ages 20-44 years (IRR=1.6, P=0.004). Blacks had lower lifetime incidence rates than non-Hispanic whites (IRR=0.75, P=0.04), Hispanics (IRR=0.64, P=0.007), and Asians (IRR=0.67, P=0.03). Asians did not differ from non-Hispanic whites in lifetime or age-specific incidence rates. These results indicate that while US Hispanics do not have greater lifetime incidence rates of acute promyelocytic leukemia, blacks have lower incidence rates of acute promyelocytic leukemia than Hispanics, non-Hispanic whites, and Asians.

Entities:  

Mesh:

Year:  2006        PMID: 16835508     DOI: 10.1097/00008469-200608000-00011

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  11 in total

1.  Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia.

Authors:  Geetanjali R Kamath; Douglas Tremblay; Alexander Coltoff; Jessica Caro; Guido Lancman; Sheena Bhalla; Vesna Najfeld; John Mascarenhas; Emanuela Taioli
Journal:  Carcinogenesis       Date:  2019-07-04       Impact factor: 4.944

2.  Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.

Authors:  Graça M Dores; Susan S Devesa; Rochelle E Curtis; Martha S Linet; Lindsay M Morton
Journal:  Blood       Date:  2011-11-15       Impact factor: 22.113

Review 3.  Acute promyelocytic leukemia in childhood.

Authors:  John Gregory; James Feusner
Journal:  Curr Oncol Rep       Date:  2009-11       Impact factor: 5.075

Review 4.  Epidemiology of childhood acute myeloid leukemia.

Authors:  Susan E Puumala; Julie A Ross; Richard Aplenc; Logan G Spector
Journal:  Pediatr Blood Cancer       Date:  2013-01-09       Impact factor: 3.167

5.  Acute leukemia in adult Hispanic Americans: a large-population study.

Authors:  R Swords; J Sznol; R Elias; J Watts; A Zelent; E Martin; F Vargas; S Bethel-Ellison; E Kobetz
Journal:  Blood Cancer J       Date:  2016-10-14       Impact factor: 11.037

6.  Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolism.

Authors:  Luca Mazzarella; Edoardo Botteri; Anthony Matthews; Elena Gatti; Davide Di Salvatore; Vincenzo Bagnardi; Massimo Breccia; Pau Montesinos; Teresa Bernal; Cristina Gil; Timothy J Ley; Miguel Sanz; Krishnan Bhaskaran; Francesco Lo Coco; Pier Giuseppe Pelicci
Journal:  Haematologica       Date:  2019-09-12       Impact factor: 9.941

7.  Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse.

Authors:  Fieke W Hoff; Chenyue W Hu; Amina A Qutub; Yihua Qiu; Marisa J Hornbaker; Carlos Bueso-Ramos; Hussein A Abbas; Sean M Post; Eveline S J M de Bont; Steven M Kornblau
Journal:  Proteomics Clin Appl       Date:  2019-02-04       Impact factor: 3.494

Review 8.  Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies.

Authors:  N I Noguera; G Catalano; C Banella; M Divona; I Faraoni; T Ottone; W Arcese; M T Voso
Journal:  Cancers (Basel)       Date:  2019-10-18       Impact factor: 6.639

9.  Acute Promyelocytic Leukemia: A Long-Term Retrospective Study in Mexico.

Authors:  Nidia Zapata-Canto; Manuel Aguilar; Luara Arana; Efren Montano; Cristian Ramos-Penafiel; Jose Antonio De la Pena; Jose Luis Alvarez-Vera; Eugenia Espitia-Rios; Juan Manuel Perez Zuniga; Eleazar Hernandez-Ruiz; Eduardo Cervera; Ramiro Espinoza-Zamora; Alejandro Sosa-Espinoza; Juan Carlos Solis-Poblano; Roberta Demichelis; David Gomez-Almaguer; Esperanza Barrera; Javier Mijangos; Ruben Solis-Armenta; Oscar de Jesus Perez; Miguel Herrera; Guillermo Diaz-Vargas; Alvaro Cabrera-Garcia; Juan Antonio Flores-Jimenez; Javier Morales-Adrian; Eva Fabiola Ramirez-Romero; Adrian Ceballos-Lopez; Victor Antonio Guillermo; Manuel Solano Manuel; Esthela Juan Lien-Chang Lourdes; Juan Ojeda-Tovar; Gladys Gomez-Perdomo; Martha Alvarado-Ibarra
Journal:  J Hematol       Date:  2021-04-27

10.  FLT3-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification.

Authors:  Andrew Y Li; Sarah M Kashanian; Bryan C Hambley; Kyle Zacholski; Vu H Duong; Firas El Chaer; Noa G Holtzman; Ivana Gojo; Jonathan A Webster; Kelly J Norsworthy; Bruce Douglas Smith; Amy E DeZern; Mark J Levis; Maria R Baer; Farin Kamangar; Gabriel Ghiaur; Ashkan Emadi
Journal:  Biology (Basel)       Date:  2021-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.